THESEUS PHARMACEUTICALS, INC. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 20 rows, 20 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2021-10-15: Reporting owner ARIAD PHARMACEUTICALS INC | TAKEDA PHARMACEUTICAL CO LTD; Form 3; Security Series A Preferred Stock; Transaction Holding.
- 2021-10-12: Reporting owner TAKEDA PHARMACEUTICAL CO LTD | ARIAD PHARMACEUTICALS INC; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2021-10-12: Reporting owner GORDON CARL L; Form 4; Security Series A Convertible Preferred Stock; Transaction C Conversion of derivative security.
- 2021-10-12: Reporting owner GORDON CARL L; Form 4; Security Series B Convertible Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2021-10-15 holding as of filing | ARIAD PHARMACEUTICALS INC | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See explanation | Holding | no price filed | 2021-10-15 | ||
| 2021-10-12 | TAKEDA PHARMACEUTICAL CO LTD | ARIAD PHARMACEUTICALS INC 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See explanation | C Conversion of derivative security | −1,615,427 0 owned after | $0.00 | 2021-10-15 | |
| 2021-10-12 | GORDON CARL L Director, 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · By OrbiMed Private Investments VII, LP | C Conversion of derivative security | −14,903,718 0 owned after | no price filed | 2021-10-14 | |
| 2021-10-12 | GORDON CARL L Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · By OrbiMed Private Investments VII, LP | C Conversion of derivative security | −873,300 0 owned after | no price filed | 2021-10-14 | |
| 2021-10-12 | GORDON CARL L Director, 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · By OrbiMed Genesis Master Fund, L.P. | C Conversion of derivative security | −436,650 0 owned after | no price filed | 2021-10-14 | |
| 2021-10-12 | Rock Springs Capital LLC | Rock Springs Capital Management LP | Rock Springs Capital Master Fund LP 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −349,320 0 owned after | no price filed | 2021-10-14 | |
| 2021-10-12 | Rock Springs Capital LLC | Rock Springs Capital Management LP | Rock Springs Capital Master Fund LP 10% Owner | 10% Owner | 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | C Conversion of derivative security | −87,329 0 owned after | no price filed | 2021-10-14 | |
| 2021-10-12 | OrbiMed Genesis GP LLC | ORBIMED ADVISORS LLC | OrbiMed Capital GP VII LLC 10% Owner | Director, 10% Owner | 10% Owner | 4 | Series A Convertible Preferred Stock Derivative · Indirect · By OrbiMed Private Investments VII, LP | C Conversion of derivative security | −14,903,718 0 owned after | no price filed | 2021-10-14 | |
| 2021-10-12 | OrbiMed Genesis GP LLC | ORBIMED ADVISORS LLC | OrbiMed Capital GP VII LLC 10% Owner | Director, 10% Owner | 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · By OrbiMed Private Investments VII, LP | C Conversion of derivative security | −873,300 0 owned after | no price filed | 2021-10-14 | |
| 2021-10-12 | OrbiMed Genesis GP LLC | ORBIMED ADVISORS LLC | OrbiMed Capital GP VII LLC 10% Owner | Director, 10% Owner | 10% Owner | 4 | Series B Convertible Preferred Stock Derivative · Indirect · By OrbiMed Genesis Master Fund, L.P. | C Conversion of derivative security | −436,650 0 owned after | no price filed | 2021-10-14 | |
| 2021-10-12 | Paster Anne-Mari | Omega Fund VI, L.P. | Stampacchia Otello | Omega Fund VI GP Manager, Ltd. | Nessi Claudio Other (Former 10% owner) | Other (Former 10% owner) | Other (Former 10% owner) | Other (Former 10% owner) | Other (Former 10% owner) | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −693,152 0 owned after | no price filed | 2021-10-14 | |
| 2021-10-06 holding as of filing | Omega Fund VI GP, L.P. | Nessi Claudio | Paster Anne-Mari | Stampacchia Otello | Omega Fund VI GP Manager, Ltd. | Omega Fund VI, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Preferred Stock Derivative · Direct | Holding | no price filed | 2021-10-06 | ||
| 2021-10-06 holding as of filing | Rock Springs Capital Management LP | Rock Springs Capital LLC | Rock Springs Capital Master Fund LP 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2021-10-06 | ||
| 2021-10-06 holding as of filing | Rock Springs Capital Management LP | Rock Springs Capital LLC | Rock Springs Capital Master Fund LP 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · See Footnote | Holding | no price filed | 2021-10-06 | ||
| 2021-10-06 holding as of filing | GORDON CARL L Director, 10% Owner | 3 | Series A Convertible Preferred Stock Derivative · Indirect · By OrbiMed Private Investments VII, LP | Holding | no price filed | 2021-10-06 | ||
| 2021-10-06 holding as of filing | GORDON CARL L Director, 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · By OrbiMed Private Investments VII, LP | Holding | no price filed | 2021-10-06 | ||
| 2021-10-06 holding as of filing | GORDON CARL L Director, 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · By OrbiMed Genesis Master Fund, L.P. | Holding | no price filed | 2021-10-06 | ||
| 2021-10-06 holding as of filing | ORBIMED ADVISORS LLC | OrbiMed Genesis GP LLC | OrbiMed Capital GP VII LLC Director, 10% Owner | 10% Owner | 10% Owner | 3 | Series A Convertible Preferred Stock Derivative · Indirect · By OrbiMed Private Investments VII, LP | Holding | no price filed | 2021-10-06 | ||
| 2021-10-06 holding as of filing | ORBIMED ADVISORS LLC | OrbiMed Genesis GP LLC | OrbiMed Capital GP VII LLC Director, 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · By OrbiMed Private Investments VII, LP | Holding | no price filed | 2021-10-06 | ||
| 2021-10-06 holding as of filing | ORBIMED ADVISORS LLC | OrbiMed Genesis GP LLC | OrbiMed Capital GP VII LLC Director, 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · By OrbiMed Genesis Master Fund, L.P. | Holding | no price filed | 2021-10-06 |